임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 중단 (진행 중)· Transthyretin Amyloid Cardiomyopathy (ATTR-CM)A Study to Evaluate the Efficacy and Safety of Concomitant Use of Eplontersen and ALXN2220 Compared With Eplontersen and Placebo for Adults Participants With ATTR-CM
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Hepatocellular CarcinomaDurvalumab and Tremelimumab With Lenvatinib as First-line Treatment in Patients With Unresectable Hepatocellular Carcinoma
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Obesity/OverweightThis is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Locally Advanced Cervical CancerA Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (IVOLGA)
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Crohn's DiseaseStudy Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Non-Small Cell Lung CancerA Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Moderate to Severe Crohn's DiseasePhase IIa Study Evaluating AZD7798 in Crohn's Disease
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Biliary Tract CancerDurvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· EGPA - Eosinophilic Granulomatosis With PolyangiitisExplore the Efficacy and Mechanism of Action of Tezepelumab in Eosinophilic Granulomatosis With Polyangiitis
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Lung CancerTo Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· HCC - Hepatocellular CarcinomaDurvalumab/Tremelimumab in Neoadjuvant and Adjuvant Setting in Patients With HCC Treated by by Percutaneous Ablation Procedure
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Hepatocellular Carcinoma (HCC)A US Study to Evaluate Transarterial Radioembolization (TARE) in Combination With Durvalumab and Bevacizumab Therapy in People With Unresectable Hepatocellular Carcinoma Amenable to TARE
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Mantle Cell Lymphoma (MCL)A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Mantle Cell LymphomaAcalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Non-Small Cell Lung Cancer (NSCLC)A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Esophageal AdenocarcinomaAdjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Advanced or Metastatic NSCLCA Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Hepatocellular CarcinomaStudy of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Chronic Obstructive Pulmonary DiseaseInhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Small Cell Lung CarcinomaDurvalumab Maintenance After Thoracic Chemoradiotherapy in Frail Small Cell Lung Cancer Patients Whose Disease is Limited to the Thorax
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Stage II-IIIB Non-small Cell Lung CarcinomaA Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Refractory Aggressive B-cell LymphomasAcalabrutinib + Liso-Cel In R/R Aggressive B-Cell Lymphomas
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Non-small Cell Lung CancerStudy to Assess the Efficacy and Safety of Adjuvant Osimertinib in NSCLC With Uncommon EGFRm
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Metastatic Pancreatic CancerOlaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Lung CancerSavolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Breast CancerStudy of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· HER2-mutant Non-Small Cell Lung CancerA Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Extensive-stage Small Cell Lung CancerPersonalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Lung CancerLow-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· NSCLCRadiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Extensive-Stage Small-Cell Lung CancerChemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· MCLAcalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Locally Advanced or Metastatic Solid TumoursSafety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Metastatic or Locally Advanced NSCLCConcomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Diffuse Large B Cell LymphomaAcalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL)
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Urothelial CarcinomaA Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Heart FailureOPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Chronic Lymphocytic LeukemiaA Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL
협력: 아스트라제네카, 로슈
- 2상모집 중단 (진행 중)· Extensive Stage Small Cell Lung CancerChemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Stage IIIA Non-small Cell Lung CancerCHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Waldenstrom MacroglobulinemiaBendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· NSCLCTreating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastA Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
리드: 아스트라제네카
- 2상모집 중단 (진행 중)· Small Cell Lung Cancer Limited StageEfficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN)
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Hepatocellular Carcinoma Non-resectableDurvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Chronic Lymphocytic LeukemiaAcalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Recurrent Moderate-Severe Chronic Graft Versus Host DiseaseAcalabrutinib for the Treatment of Chronic Graft Versus Host Disease
협력: 아스트라제네카
- 2상모집 중단 (진행 중)· Metastatic Pancreatic AdenocarcinomaMaintenance With Olaparib or Selumetinib + Durvaluma for m-PDAC Guided by BRCAness and KRAS Status.
협력: 아스트라제네카
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.